Log In
BCIQ
Print this Print this
 

illumigene C. difficile

  Manage Alerts
Collapse Summary General Information
Company Meridian Bioscience Inc.
DescriptionMolecular-based platform based on DNA amplification utilizing loop amplification (LAMP) technology for diagnosing Clostridium difficile infection
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDiagnose Clostridium difficile infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today